Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.54
+2.52%
Mkt Cap $425.11M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
Implied Upside
+186.9%
Consensus $24.50 vs current $8.54
NASDAQ·Healthcare·Biotechnology
$8.54
+2.52%
Mkt Cap $425.11M
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
+186.9%
Consensus $24.50 vs current $8.54